Ani Pharmaceuticals (ANIP) Net Margin (2010 - 2026)
Ani Pharmaceuticals' Net Margin came in at 9.29% for Q2 2026, up 5.44 percentage points from 3.85% a year earlier but down 3.13 percentage points from the prior quarter.
Ani Pharmaceuticals (ANIP) Net Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ani Pharmaceuticals reported Net Margin of 11.04%, up 12.62 percentage points year-over-year; for FY2025, it came in at 8.74%, up 12.02 percentage points from FY2024.
- Net Margin carries a five-year change of +19.55 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -3.28% in FY2024 (-6.80 pp), 3.52% in FY2023 (+19.18 pp), -15.65% in FY2022 (+4.15 pp) and -19.80% in FY2021 (-8.98 pp).
- The five-year range for quarterly Net Margin is -39.93% (Q4 2021) to 12.95% (Q1 2024).
- Year-over-year, Net Margin has increased for five consecutive quarters, with an average year-over-year change of +3.20 percentage points over the last eight quarters.
- The fastest year-over-year change in Net Margin over five years came in Q4 2022 (a gain of 34.99 percentage points), and the weakest in Q4 2021 (a drop of 33.61 percentage points).
- Business Quant data shows ANIP's Net Margin at 12.42% (Q1 2026), 11.13% (Q4 2025) and 11.53% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Ani Pharmaceuticals | 1.73 Bn | 512.62 Mn | 165.89 Mn | 9.29% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.29% |
| Mar 31, 2026 | 12.42% |
| Dec 31, 2025 | 11.13% |
| Sep 30, 2025 | 11.53% |
| Jun 30, 2025 | 3.85% |
| Mar 31, 2025 | 7.75% |
| Dec 31, 2024 | -5.61% |
| Sep 30, 2024 | -16.57% |
| Jun 30, 2024 | -1.95% |
| Mar 31, 2024 | 12.95% |
| Dec 31, 2023 | 0.57% |
| Sep 30, 2023 | 7.23% |
| Jun 30, 2023 | 5.01% |
| Mar 31, 2023 | 0.97% |
| Dec 31, 2022 | -4.93% |
| Sep 30, 2022 | -10.74% |
| Jun 30, 2022 | -20.76% |
| Mar 31, 2022 | -31.85% |
| Dec 31, 2021 | -39.93% |
| Sep 30, 2021 | -8.54% |
Ani Pharmaceuticals Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();